Price
$3.68
Decreased by -9.58%
Dollar volume (20D)
20.83 M
ADR%
11.72
Earnings report date
Oct 31, 2025
Shares float
73.98 M
Shares short
21.66 M [29.28%]
Shares outstanding
178.20 M
Market cap
778.72 M
Beta
2.41
Price/earnings
N/A
20D range
3.51 5.17
50D range
1.18 5.17
200D range
1.11 5.17

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor.

The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome.

Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Aug 6, 25 0.00
Increased by +100.00%
-0.43
Increased by +100.00%
May 8, 25 -0.40
Increased by +9.09%
-0.44
Increased by +9.09%
Feb 28, 25 -0.31
Increased by +56.94%
-0.49
Increased by +36.73%
Nov 13, 24 -0.44
Increased by +20.00%
-0.49
Increased by +10.20%
Aug 8, 24 -0.46
Increased by +2.13%
-0.49
Increased by +6.12%
May 10, 24 -0.44
Increased by 0.00%
-0.47
Increased by +6.38%
Mar 1, 24 -0.72
Decreased by -28.57%
-0.51
Decreased by -41.18%
Nov 3, 23 -0.55
Increased by +24.66%
-0.46
Decreased by -19.57%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 1.45 M
Increased by +146.02%
-51.89 M
Decreased by -13.39%
Decreased by -3.57 K%
Increased by +53.91%
Dec 31, 24 2.18 M
Decreased by -91.50%
-42.28 M
Increased by +35.60%
Decreased by -1.94 K%
Decreased by -657.97%
Sep 30, 24 209.00 K
Increased by +N/A%
-52.52 M
Decreased by -3.57%
Decreased by -25.13 K%
Decreased by N/A%
Jun 30, 24 37.77 M
Increased by +N/A%
-55.33 M
Decreased by -30.53%
Decreased by -146.47%
Decreased by N/A%
Mar 31, 24 591.00 K
Increased by +N/A%
-45.76 M
Decreased by -16.15%
Decreased by -7.74 K%
Decreased by N/A%
Dec 31, 23 25.69 M
Increased by +393.13%
-65.64 M
Decreased by -67.10%
Decreased by -255.50%
Increased by +66.11%
Sep 30, 23 0.00
Decreased by N/A%
-50.71 M
Decreased by -41.99%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-42.38 M
Decreased by -18.92%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY